Omada Health, Inc. (OMDA) – What Are Researchers Thinking About This Stock?

Omada Health, Inc. (NASDAQ:OMDA – Get Free Report) has earned an average rating of “Moderate Buy” from the fifteen research firms that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and eleven have given a buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $25.92.

OMDA has been the topic of a number of recent analyst reports. Zacks Research lowered Omada Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 4th. Wall Street Zen upgraded shares of Omada Health from a “hold” rating to a “buy” rating in a report on Sunday, October 11th. Citigroup reaffirmed an “outperform” rating on shares of Omada Health in a research note on Friday, August 14th. Barclays lowered their price objective on shares of Omada Health from $24.00 to $22.00 and set an “overweight” rating for the company in a research report on Friday, November 6th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Omada Health from $30.00 to $25.00 and set an “overweight” rating on the stock in a research note on Monday.

Check Out Our Latest Stock Report on OMDA

Insider Activity

In related news, President Wei-Li Shao sold 4,036 shares of the stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $21.85, for a total value of $88,186.60. Following the transaction, the president owned 295,313 shares of the company’s stock, valued at $6,452,589.05. This represents a 1.35% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Steven L. Cook sold 6,800 shares of the firm’s stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $21.86, for a total value of $148,648.00. Following the transaction, the chief financial officer owned 173,906 shares in the company, valued at $3,801,585.16. The trade was a 3.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 79,322 shares of company stock valued at $1,720,914. Corporate insiders own 6.38% of the company’s stock.

Hedge Funds Weigh In On Omada Health

A number of hedge funds and other institutional investors have recently made changes to their positions in OMDA. Sterling Capital Management LLC grew its holdings in Omada Health by 1,161.6% during the 3rd quarter. Sterling Capital Management LLC now owns 1,577 shares of the company’s stock worth $33,000 after acquiring an additional 1,452 shares in the last quarter. Integrated Wealth Concepts LLC bought a new stake in shares of Omada Health in the 2nd quarter valued at about $53,000. State of Alaska Department of Revenue bought a new stake in shares of Omada Health in the 3rd quarter valued at about $59,000. Versant Capital Management Inc raised its holdings in shares of Omada Health by 319.3% in the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after purchasing an additional 2,283 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. purchased a new stake in shares of Omada Health in the 3rd quarter worth approximately $70,000.

Omada Health Price Performance

Shares of NASDAQ:OMDA opened at $13.17 on Friday. The firm has a market capitalization of $817.07 million, a PE ratio of 67.05 and a beta of 2.13. The business has a 50 day simple moving average of $18.80 and a two-hundred day simple moving average of $17.69. Omada Health has a 1 year low of $10.28 and a 1 year high of $25.45.

Omada Health (NASDAQ:OMDA – Get Free Report) last issued its quarterly earnings results on Thursday, November 5th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.08. Omada Health had a return on equity of 5.71% and a net margin of 4.21%. The firm had revenue of $91.31 million for the quarter. Equities research analysts expect that Omada Health will post 0.09 EPS for the current fiscal year.

About Omada Health

(Get Free Report)

Omada Health is a U.S. digital health company that provides virtual care programs for people managing chronic conditions. Its services address areas including diabetes, prediabetes, hypertension, musculoskeletal conditions and weight management. The company combines digital tools, personalized health coaching and, where appropriate, clinical support to help members build health habits and manage their care. Programs may include mobile-app-based guidance and connected devices, such as scales or blood pressure monitors.

Featured Stories

Analyst Recommendations for Omada Health (NASDAQ:OMDA)

Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.